Luis Manuel Domínguez Rodríguez

Luis Manuel Domínguez Rodríguez

Auto-generated profile, based on publicly available information

Luis Manuel Domínguez Rodríguez

Cardiology Department, University Hospital Ramon y Cajal, Madrid, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
ASAngel Sánchez-Recalde
Angel Sánchez-Recalde
LDLuis M. Domínguez-Rodríguez
Luis M. Domínguez-Rodríguez
LRLiesbeth Rosseel
Liesbeth Rosseel
LNLuis Nombela-Franco
Luis Nombela-Franco
RPRoman Pfister
Roman Pfister
JZJosé L. Zamorano
José L. Zamorano

18 December 2024 in European Journal of Heart Failure
Verified
Journal Article
Open access
LDLuis Manuel Domínguez-Rodríguez
Luis Manuel Domínguez-Rodríguez
DDDavid Dobarro
David Dobarro
CICarla Iglesias-Otero
Carla Iglesias-Otero
MCMaría G. Crespo-Leiro
María G. Crespo-Leiro
SRSergio Raposeiras-Roubín
Sergio Raposeiras-Roubín
JZJosé Luis Zamorano
José Luis Zamorano
Aims: No study has analyzed the impact of guideline-directed medical therapy in preventing heart failure (HF) relapse in patients with arrhythmia-induced cardiomyopathy (AiCM) following left ventricular ejection fraction (LVEF) improvement. Methods and results: We analyzed data from a single-center cohort of 200 patients admitted for HF, LVEF <50% and cardiac arrhythmia considered by cardiologists to be the precipitating cause of the episode. The primary endpoint was time-to-HF relapse, defined as the composite of readmission for HF, Emergency Department (ED) visit for HF, or significant decline in LVEF. Changes in medication were recorded and a time-varying multivariate Cox regression was performed. After a median follow-up period of 6.14 years, diagnostic confirmation was achieved in 188 out of the initial 200 patients with suspected AiCM. A total of 89 patients (47.3%) met the primary endpoint. RAS inhibitors (adjusted hazard ratio (HR) 0.50 [0.31–0.81]; p = 0.005) and beta-blockers (adjusted HR 0.48 [0.28–0.81]; p = 0.006) were associated with a lower incidence of relapse. Mineralocorticoid receptor antagonists were associated with a significantly lower incidence of ED visits for HF (adjusted HR 0.38 [0.15–0.95]; p = 0.038), but did not achieve statistical significance for the combined primary endpoint. Antiarrhythmic drugs did not show a significant impact on the primary endpoint. Conclusion: Maintaining RAS inhibitors and beta-blockers was associated with a significantly lower incidence of relapse in the setting of AiCM with improved LVEF.

6 October 2025 in JACC
Verified
Journal Article
Closed access
Clara BonanadClara Bonanad
Clara Bonanad
SGSergio García-Blas
Sergio García-Blas
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos
RGRafael Gonzalez-Manzanares
Rafael Gonzalez-Manzanares
JSJuan Sanchís
Juan Sanchís
SRSergio Raposeiras-Roubín
Sergio Raposeiras-Roubín

17 September 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
JSJosé A. Salinas-Casanova
José A. Salinas-Casanova
ASAna Pardo Sanz
Ana Pardo Sanz
LTLuisa Salido Tahoces
Luisa Salido Tahoces
AGAriana González Gómez
Ariana González Gómez
CLCovadonga Fernández-Golfín Lobán
Covadonga Fernández-Golfín Lobán
ÁSÁngel Sánchez-Recalde
Ángel Sánchez-Recalde

25 May 2026 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
JSJosé A. Salinas-Casanova
José A. Salinas-Casanova
ASAna Pardo Sanz
Ana Pardo Sanz
LTLuisa Salido Tahoces
Luisa Salido Tahoces
LRLuis M. Domínguez Rodríguez
Luis M. Domínguez Rodríguez
AIAnder Larrea Iñarra
Ander Larrea Iñarra
ÁSÁngel Sánchez-Recalde
Ángel Sánchez-Recalde

28 October 2026 in JACC: Advances
Verified
Journal Article
Open access
LDLuis Manuel Domínguez-Rodríguez
Luis Manuel Domínguez-Rodríguez
LNLuis Nombela
Luis Nombela
RPRoman Pfister
Roman Pfister
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos
CBChristian Butter
Christian Butter
ASAngel Sánchez-Recalde
Angel Sánchez-Recalde